Trisenox arsenic trioxide: Compassionate use study; marketed in U.S. and EU to treat refractory APL

In a French compassionate use program of Trisenox in 18 patients with relapsed or refractory

Read the full 150 word article

How to gain access

Continue reading with a
two-week free trial.